Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Smart insulin pump trial aims to simplify diabetes management

NCT ID NCT07320495

First seen Jan 11, 2026 · Last updated May 23, 2026 · Updated 18 times

Summary

This study tests a new automated insulin delivery system (the Medtrum TouchCare Nano with APGO algorithm) in 200 adults with type 1 diabetes. The system automatically adjusts insulin based on blood sugar levels, aiming to keep glucose in a healthy range. Researchers will measure changes in HbA1c and time in target blood sugar range over 24 weeks to see if the system is safe and effective in real-world conditions.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS, TYPE 1 are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • 3rd Department of Internal Medicine, 1st Faculty of Medicine, Charles University, Prague, Czechia

    RECRUITING

    Prague, Czechia

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

Conditions

Explore the condition pages connected to this study.